UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

Thrombosis and haemostasis, 2020-11, Vol.120 (11), p.1594-1596

2020

Volltextzugriff (PDF)

G-protein-coupled receptors signaling pathways in new antiplatelet drug development

Arteriosclerosis, thrombosis, and vascular biology, 2015-03, Vol.35 (3), p.500-512

2015

Volltextzugriff (PDF)

First report of the point-of-care TEG: A technical validation study of the TEG-6S system

Platelets (Edinburgh), 2016-10, Vol.27 (7), p.642-649

2016

Volltextzugriff (PDF)

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry

Platelets (Edinburgh), 2024-12, Vol.35 (1), p.2298352-2298352

2024

Volltextzugriff (PDF)

The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation

Platelets (Edinburgh), 2022-05, Vol.33 (4), p.520-530

2022

Volltextzugriff (PDF)

Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes

Thrombosis and haemostasis, 2014-04, Vol.111 (4), p.713-724

2014

Volltextzugriff (PDF)

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

Thrombosis and haemostasis, 2021-04, Vol.121 (4), p.422-432

2021

Volltextzugriff (PDF)

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

Thrombosis research, 2005, Vol.115 (1), p.89-94

2005

Volltextzugriff (PDF)

Identifying the vulnerable patient: pericoronary Adipose tissue attenuation on computed tomography

Journal of thrombosis and thrombolysis, 2024-08, Vol.57 (6), p.877-879

2024

Volltextzugriff (PDF)

Platelet-Mediated Thrombosis: From Bench to Bedside

Circulation research, 2016-04, Vol.118 (9), p.1380-1391

2016

Volltextzugriff (PDF)

The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management

Journal of thrombosis and thrombolysis, 2024-08

2024

Volltextzugriff (PDF)

Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

Arteriosclerosis, thrombosis, and vascular biology, 2016-01, Vol.36 (1), p.189-197

2016

Volltextzugriff (PDF)

Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial

Platelets (Edinburgh), 2017-03, Vol.28 (2), p.187-193

2017

Volltextzugriff (PDF)

Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy

Journal of thrombosis and haemostasis, 2020-01, Vol.18 (1), p.23-35

2020

Volltextzugriff (PDF)

New interest in fibrinogen as an ischemic risk factor

Journal of thrombosis and thrombolysis, 2024-08

2024

Volltextzugriff (PDF)

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests

Journal of thrombosis and thrombolysis, 2021-11, Vol.52 (4), p.992-998

2021

Volltextzugriff (PDF)

Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?

Blood coagulation & fibrinolysis, 2021-12, Vol.32 (8), p.544-549

2021

Volltextzugriff (PDF)

Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B 2 and agonist-induced platelet aggregation

Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.260

2021

Volltextzugriff (PDF)

Clopidogrel resistance?

Thrombosis research, 2007-01, Vol.120 (3), p.311-321

2007

Volltextzugriff (PDF)

Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory

Journal of thrombosis and thrombolysis, 2024-04, Vol.57 (4), p.566-575

2024

Volltextzugriff (PDF)

Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial

Thrombosis and haemostasis, 2021-10, Vol.121 (10), p.1376-1386

2021

Volltextzugriff (PDF)

An update on novel therapies for treating patients with arterial thrombosis

Expert review of hematology, 2023-08, Vol.16 (8), p.593-605

2023

Volltextzugriff (PDF)

Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response

Journal of thrombosis and thrombolysis, 2024-01, Vol.57 (1), p.21-28

2024

Volltextzugriff (PDF)

Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure

Thrombosis and haemostasis, 2023-06, Vol.123 (6), p.627-640

2023

Volltextzugriff (PDF)

Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B2 and agonist-induced platelet aggregation

Journal of thrombosis and thrombolysis, 2021-02, Vol.51 (2), p.260-264

2021

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Aktive Filter

SprachePolnisch

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(67)

Sprache

Englisch
(67)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(65)
Science & Technology
(65)
Cardiovascular System & Cardiology
(51)
Peripheral Vascular Disease
(51)
Humans
(46)
Male
(28)
Female
(27)
Middle Aged
(25)
Aged
(24)
Cardiac & Cardiovascular Systems
(24)
Cardiology
(22)
Medicine
(22)
Medicine & Public Health
(22)
Clopidogrel
(17)
Platelet Aggregation - Drug Effects
(16)
Platelet Aggregation
(14)
Thrombelastography
(14)
Aspirin
(13)
Biological And Medical Sciences
(13)

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry

G-protein-coupled receptors signaling pathways in new antiplatelet drug development

First report of the point-of-care TEG: A technical validation study of the TEG-6S system

Utility of VerifyNow to assess the immediate pharmacodynamic response of chewed and swallowed aspirin: comparison with aggregometry

The role of viscoelastic testing in assessing peri-interventional platelet function and coagulation

Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes

The East Asian Paradox: An Updated Position Statement on the Challenges to the Current Antithrombotic Strategy in Patients with Cardiovascular Disease

The difference between clopidogrel responsiveness and posttreatment platelet reactivity

Identifying the vulnerable patient: pericoronary Adipose tissue attenuation on computed tomography

Platelet-Mediated Thrombosis: From Bench to Bedside

The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management

Cell-Penetrating Pepducin Therapy Targeting PAR1 in Subjects With Coronary Artery Disease

Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial

Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy

New interest in fibrinogen as an ischemic risk factor

International COVID-19 thrombosis biomarkers colloquium: COVID-19 diagnostic tests

Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm?

Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B 2 and agonist-induced platelet aggregation

Clopidogrel resistance?

Development of a routine bedside CYP2C19 genotype assessment program for antiplatelet therapy guidance in a community hospital catheterization laboratory

Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial

An update on novel therapies for treating patients with arterial thrombosis

Early assessment of the pharmacokinetic and pharmacodynamic effects following acetylsalicylic acid loading: toward a definition for acute therapeutic response

Post-PCI Risk Assessment by Inflammation Activity According to Disease Acuity and Time from Procedure

Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B2 and agonist-induced platelet aggregation

Aktive Filter

Suchergebnisse filtern